In the MILES-4 study patients with non-squamous histology are randomized , in a factorial design with 1111 ratio , to four arms : gemcitabine ( A ) , cisplatin/gemcitabine ( B ) , pemetrexed ( C ) , cisplatin/pemetrexed ( D ) .